ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 896 filers reported holding ASTRAZENECA PLC in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $426,560 | +15.8% | 6,299 | +22.4% | 0.02% | +7.1% |
| Q2 2023 | $368,381 | +1.0% | 5,147 | -2.1% | 0.01% | -6.7% |
| Q1 2023 | $364,829 | +0.9% | 5,256 | -1.4% | 0.02% | -6.2% |
| Q4 2022 | $361,573 | +17.8% | 5,333 | -4.6% | 0.02% | +6.7% |
| Q3 2022 | $307,000 | -9.2% | 5,591 | +9.3% | 0.02% | -6.2% |
| Q2 2022 | $338,000 | -17.2% | 5,114 | -27.0% | 0.02% | -5.9% |
| Q4 2021 | $408,000 | -5.3% | 7,004 | -2.3% | 0.02% | -15.0% |
| Q3 2021 | $431,000 | +2.1% | 7,168 | +2.5% | 0.02% | -4.8% |
| Q2 2021 | $422,000 | +22.7% | 6,992 | +0.6% | 0.02% | +5.0% |
| Q1 2021 | $344,000 | -10.4% | 6,950 | -9.5% | 0.02% | -28.6% |
| Q4 2020 | $384,000 | +16.7% | 7,682 | +27.8% | 0.03% | -3.4% |
| Q3 2020 | $329,000 | +31.6% | 6,013 | +27.4% | 0.03% | +16.0% |
| Q2 2020 | $250,000 | +18.5% | 4,718 | +11.5% | 0.02% | -3.8% |
| Q4 2019 | $211,000 | – | 4,230 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |